Indicative listing context
TRex Bio Stock Price ($14 Nasdaq IPO: TRXB) & Pre-IPO Biotech Peers
Start Biotech Peer Allocation from $25 → · Stripe checkout (Card, Apple Pay, Link · no password · terms).
TRex Bio priced its IPO of 8,333,334 shares at $14.00 per share on October 8, 2026 ($116.7 million gross proceeds), with SEC registration effectiveness dated October 8, 2026 and Nasdaq Global Select trading under symbol TRXB expected October 9, 2026. Because TRex Bio priced its public Nasdaq offering (TRXB), public-market buyers use standard retail brokerages, while pre-IPO biotech investors on Segmara can start allocations from $25 ($1.00 Priority Hold, no password) via Stripe across Aspen Neuroscience, Iambic Therapeutics, Isomorphic Labs, and Precision Neuroscience ($8.18/sh).
Full shares under $10 on Stripe: Aalo ($1.00) · ID.me ($1.40) · Chainalysis ($6.20) · Scale AI ($8.78)
Just researching? Get free TRex Bio mark alerts by email
Indicative private-market reference marks. Direct share allocations and portfolio orders are managed through your Segmara account.
Private-share data lens
Public round-by-round marks are incomplete for this company. Segmara shows the listing mark and keeps the seed-to-IPO analysis focused on verifiable funding, tender, or secondary signals.
| Stage | Date | Valuation / price signal | Why it matters |
|---|---|---|---|
| Seed / early | Private | Not reliably public | Do not invent a seed price when the source set is thin. |
| Growth rounds | Private | Company and market sources vary | Use public sources and official company releases. |
| Segmara listing | Current | No indicative price yet | Indicative reference only, not a quote or an offer. |
| IPO status | Current | No public ticker shown here | Watch official company releases and the free Segmara IPO calendar. |
Seed-to-IPO path
Illustrative completeness map. Longer bars mean stronger public data or more useful current pricing context, not lower risk.
Pre-IPO Allocation
Request TRex Bio shares directly.
Start from $25 ($1.00 Priority Hold, no password) via Stripe (Card, Apple Pay, Link) to fund USD portfolio credits toward TRex Bio shares.
Full shares under $20: Aalo ($1.00) · ID.me ($1.40) · Chainalysis ($6.20) · Precision ($8.18) · Scale AI ($8.78) · Huntress ($19.03)
1Indicative mark: No indicative price yet
2Start from $25 ($1 Hold) via Stripe checkout
3Complete your TRex Bio share order & track in portfolio
AI-ready data summary
A structured extraction layer for this article: catalogue numbers, price context, chart values, and route-specific facts that search and AI systems can read directly from the page.
| Metric | Value | Context |
|---|---|---|
| Canonical route | /trex-bio-stock-price | Stable URL path for AI and search extraction. |
| Article title | TRex Bio Stock Price ($14 Nasdaq IPO: TRXB) & Pre-IPO Biotech Peers | Main page topic. |
| Attached public sources | 5 | Number of citation links rendered at the bottom of the article. |
| Segmara listed companies | 148 | Live private-company listings in the public catalogue. |
| Priced listings | 37 | Catalogue listings with visible indicative or direct marks. |
| Listings without an indicative price | 111 | Catalogue listings where a public price is intentionally not invented. |
| Company | TRex Bio | Named company covered by this page. |
| Symbol label | TREX | Segmara display symbol; not a public stock ticker unless separately stated. |
| Sector | Biotechnology | Catalogue sector used for comparison and internal linking. |
| Listing structure | Request | How the listing is categorized on Segmara. |
| Segmara mark | No indicative price yet | Visible listing mark, or no indicative price yet. |
| Sector peer count | 3 | Number of live Segmara listings in Biotechnology. |
| Structure peer count | 111 | Number of live Segmara listings categorized as Request. |
Data fingerprint chart
| Stage | Timing | Price / valuation signal | Interpretation |
|---|---|---|---|
| Formation | Private | Early ownership | The first value creation happens before ordinary public-market access. |
| Growth rounds | Private | Institutional repricing | Later rounds and tenders create the price history buyers study. |
| Segmara listing | Current | No indicative price yet | Indicative reference only, not a quote or an offer. |
| Exit path | Future | IPO, tender, acquisition, or continued private status | Liquidity timing remains company-specific. |
| Chart metric | Score | Interpretation |
|---|
Analytical lens
Search intent
Searches like 'TRex Bio Stock Price ($14 Nasdaq IPO: TRXB) & Pre-IPO Biotech Peers' are research questions: what a filing or a company statement confirms, what has only been reported, and what is still unknown.
What counts as a listing step
For an IPO, the primary record is a registration statement filed with the securities regulator of the listing market, such as an S-1 or F-1 on SEC EDGAR for a US listing. Funding rounds, valuations and secondary-market prices are context, not listing steps.
Segmara role
Segmara provides pre-IPO share allocations, Stripe-funded USD portfolio credits from $25 ($1.00 Priority Hold), and dated indicative reference marks across 140+ private companies on Segmara. Nothing on this page is investment advice.
How pre-IPO share access works
Standard Segmara allocation path
1. SearchStart with the company or pre-IPO question
2. ListingReview indicative mark and structure context
3. CheckoutFund from $25 ($1 Priority Hold) via Stripe, no password
4. AllocationRequest pre-IPO shares and track settlement in your portfolio
What happens in your portfolio
Key takeaways
- TRex Bio priced its IPO of 8,333,334 shares at $14.00 per share on October 8, 2026 ($116.7 million gross proceeds), with SEC registration effectiveness dated October 8, 2026 and Nasdaq Global Select trading under symbol TRXB expected October 9, 2026.
- Public TRXB shares trade through standard Nasdaq brokerages rather than private secondary transfers.
- Compare still-private biotech & neurotech listings on Segmara from $25 ($1.00 Priority Hold via Stripe, no password), including Aspen Neuroscience, Iambic Therapeutics, Isomorphic Labs, and Precision Neuroscience ($8.18/sh).
Risk notes
- Post-IPO biotech equities carry clinical trial, regulatory, lockup-expiration, and public market volatility risks.
- Still-private biotech peers on Segmara involve illiquidity, transfer restrictions, and issuer approval conditions.
- Allocation availability on private listings depends on counterparty supply, eligibility, and Segmara portfolio review.
Public source links
- TRexBio Announces Pricing of Initial Public Offering (TRex Bio, Inc. via GlobeNewswire, October 8, 2026)
- Notice of effectiveness for the TRex Bio, Inc. S-1, File No. 333-299018 (SEC EDGAR, October 8, 2026)
- TRex Bio, Inc. amended Form S-1 (SEC EDGAR, October 5, 2026)
- TRex Bio, Inc. Form S-1 (SEC EDGAR, September 18, 2026)
- TRex Bio, Inc. filing index, CIK 0002139097 (SEC EDGAR, checked October 9, 2026)
PRE-IPO ALLOCATION
Explore active pre-IPO share allocations from $25
Start from $25 in USD portfolio credits via Stripe (no password required) toward 140+ active private companies including OpenAI, Anthropic, xAI, Anduril, Databricks, and Canva.
Top private peers from $25: Precision ($8.18 →) · Aspen ($25 →) · Iambic ($25 →) · Isomorphic Labs ($25 →)
Related reviews
Questions
How do I request pre-IPO shares on Segmara?
Start from $25 ($1.00 Priority Hold, no password) via Stripe checkout or select any of 140+ live private-company listings on Segmara to submit a share allocation request.
How are indicative marks and allocations handled?
Displayed marks are dated indicative references from recent private rounds and secondary activity. Final allocation terms, eligibility, and transfer milestones are tracked in your Segmara portfolio.
Is Segmara affiliated with the named company or platform?
No. Segmara is not affiliated with TRex Bio or any named issuer, affiliate, investor, underwriter, or platform referenced on this page.
Did TRex Bio price its Nasdaq IPO?
Yes. TRex Bio priced its IPO of 8,333,334 shares at $14.00 per share on October 8, 2026 ($116.7 million gross proceeds), with SEC registration effectiveness dated October 8, 2026 and Nasdaq Global Select trading under symbol TRXB expected October 9, 2026.
Which still-private biotech companies can I access on Segmara instead?
Compare and start pre-IPO allocations from $25 ($1.00 Priority Hold, no password) via Stripe across Aspen Neuroscience, Iambic Therapeutics, Isomorphic Labs, and Precision Neuroscience ($8.18/sh).
Are there full pre-IPO neurotech or biotech shares under $20 on Segmara?
Yes. Precision Neuroscience is priced at $8.18/share on Segmara (1 full share via Stripe), alongside Aalo Atomics ($1.00/unit), ID.me ($1.40/sh), Chainalysis ($6.20/sh), Scale AI ($8.78/sh), and Huntress ($19.03/sh).
Pre-IPO Allocation
Request TRex Bio shares on Segmara.
Start from $25 ($1 Priority Hold available) via Stripe with no password required, fund USD portfolio credits, and request a pre-IPO allocation in TRex Bio.
Full shares under $20: Aalo ($1.00) · ID.me ($1.40) · Chainalysis ($6.20) · Precision ($8.18) · Scale AI ($8.78) · Huntress ($19.03)